Parents on GLP-1s face scrutiny over body changes' impact on children

Children notice everything. They see a parent's changing silhouette. They hear the refrigerator door open less often. They watch a body transform over weeks or months, and they form questions—some asked aloud, many silent. Now, as millions of adults use GLP-1 medications like Ozempic and Wegovy to lose weight, pediatricians and child psychologists are raising a quieter concern: what are kids learning when they watch their parents reshape themselves through pharmaceutical intervention?

The medications themselves are not new. GLP-1 receptor agonists were developed decades ago to treat type 2 diabetes. But their appetite-suppressing effects made them wildly popular for weight loss, and the cultural moment around them has shifted dramatically. What was once a medical tool for a specific condition became a lifestyle choice, then a status symbol, then a household conversation. Parents are using them openly. And their children are watching.

The worry isn't that parents are making a bad choice for themselves. It's that children—who are still forming their understanding of bodies, health, and what it means to feel uncomfortable in your own skin—are absorbing a particular message: that significant body change is achievable through medication, that it's normal and desirable, and that it might be something they should consider for themselves. Medical experts are now urging parents to have explicit conversations with their kids about why they're taking these drugs, what the medications do, and what they don't do. The silence, they argue, is more dangerous than the truth.

Some parents have already put their children on GLP-1 medications. The practice remains rare and medically controversial—these drugs were not designed for pediatric weight loss, and long-term effects in young people remain unknown. But the fact that it's happening at all signals how normalized the medications have become. A child watching a parent lose weight rapidly might reasonably wonder: if it works for them, why not for me? The answer requires a conversation many families haven't had.

Loma Linda University Health and other medical institutions have begun issuing guidance to parents, emphasizing transparency. The recommendation is straightforward but not simple: talk to your kids. Explain what the medication does. Explain why you're taking it. Explain that it's not a magic solution, that it requires behavioral change, that it's not appropriate for everyone. Explain, in age-appropriate language, that bodies are complex and that weight is only one measure of health. The absence of this conversation leaves children to fill in the blanks themselves, often with incomplete or distorted information.

The broader concern is about modeling. Parents teach children how to live through example as much as through words. When a child sees a parent use medication to achieve a body goal, they're learning something about how problems get solved, about what bodies should look like, and about the role of pharmaceuticals in everyday life. If that modeling happens without context, without conversation, without acknowledgment of complexity, it can contribute to unhealthy relationships with food, exercise, medication, and the body itself—relationships that can persist into adulthood.

This is not an argument against GLP-1 use. It's an argument for intentionality. Parents who choose these medications are making a decision about their own health. But that decision doesn't happen in isolation. It happens in a home where children are learning, watching, and forming beliefs about what's normal and what's possible. The medical community is essentially saying: if you're going to do this, do it with your eyes open to what your children might be learning. Have the conversation. Be honest. Acknowledge the complexity. Don't let the visible change speak for itself.